David S. Kaplan, MD
- 2Articles
- 3.7KReads1
- 2002–2005Active
- 7Collaborators
- 31Citations2
About
David S. Kaplan, MD, has published research focused on the use of selective serotonin reuptake inhibitors in the treatment of irritable bowel syndrome. His work includes pilot studies investigating citalopram and paroxetine in this patient population. Kaplan's contributions appeared in Psychiatrist.com between 2002 and 2005, often collaborating with Ahmad Hameed, Prakash S. Masand, Sanjay Gupta, Subhdeep Virk, and Thomas L. Schwartz.
Publications
1 Read counts for articles published before 2020 may include some non-human traffic.
2 Citation counts provided by Crossref.
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
